Didier Moret

BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA.

Gallien Bois Impregnes SA manufactures wooden pallets and sawmilling. The company was founded in 1989 and is headquartered in Craponne-sur-Arzon, France.

Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France.

Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US.

Vandemoortele NV engages in the manufacture and sale of food products. It operates through the bakery products and margarines, culinary oils and fats business lines. Its products include sweet treats, patisserie, bread, and pastry. The company was founded in 1899 and is headquartered in Ghent, Belgium.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.

Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa.

Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France.

Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland.

Fruytier Finance & Trading NV is an investment holding Belgian company founded in 1990. The private company is based in Marche-en-Famenne, Belgium. The company functions as an investment holding company. and has subsidiaries in Belgium and Germany.

Rabotage & Sechage du Bois SA supplies and distributes raw wood products. It provides wood to the carpentry, heating, furniture and paper industries. The company is headquartered in Marche-en-Famenne, Belgium.

ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France.

Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

Cyanide SA develops video games. It offers sport, fantasy, and role plaing game which include Blood Bowl, Game of Thrones and Of Orcs. The company was founded by Patrick Pligersdorffer in 2000 and is headquartered in Nanterre, France.

Fruytier Bourgogne SAS is a French company that engages in the sawing and planing of wood. The private company was founded in 2007 and is based in La Roche-en-Brenil, France.

Fruytier Scierie SA wholesales and distributes softwood & wooden products. The firm mainly produces spruce, douglas, larch, and pine. The company was founded in 1986 and is headquartered in Marloie-Marche, Belgium.

Swenden NV manufactures and distributes non metallic mineral products. The firm also provides glass and construction materials The company was founded on December 13, 1983 and is headquartered in Rumst, Belgium.

Part of Algemeen Kantoor Voor Zakenbeheer Alkaza, Swenden Industrie SA provides investment services. The company is based in Rumst, Belgium. The CEO of the Belgian company is Michel Swenden.

Part of Fruytier Finance & Trading NV, Karl Decker GmbH is a German company that distributes lumber, plywood, and millwork. The company is based in Hochscheid, Germany. The CEOs of the company are Piet Fruytier, Axel Salzsäuler.

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.

Gudrun Immo NV operates as a financial holding company with activities in the chocolates and truffles industry. The company was founded on March 4, 1967 and is headquartered in Lier, Belgium.

Alter Pharma NV provides professional outsourcing services. The company was founded on July 15, 2010 and is headquartered in Frameries, Belgium.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France.

Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.

Chocolade werken Gudrun NV produces chocolates and truffles. It engages in development, production, packaging and commercialization of real Belgian chocolates and truffles. The firm also offers Individual solutions for each of the categories in the chocolate market. The company was founded in 1942 and is headquartered in Lier, Belgium.